Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration

1 Sept 2020

Abstract excerpt

Here we discuss antibody, cell and gene-based therapies that are currently available and under investigation for both wet and dry age-related macular degeneration (AMD). We initially discuss ocular anatomy, AMD modelling as well as the underlying pathophysiology of AMD. The antibody-based trials which have revolutionised the management of wet AMD are reviewed. The latest concepts in antibody therapy for wet AMD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments
Share to Retinal Imaging and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32982165
DOI: 10.2147/btt.s252581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular DegenerationPMID 32982165Read ↗

Gene therapy for age-related macular degeneration: a promising frontier in vision preservationSemantic proximity Read ↗

New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity Read ↗

A New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity Read ↗

AMD and Stem Cell-Based TherapiesSemantic proximity Read ↗

A Systematic Review; Efficacy Assessment of Novel Therapy in Treating Age-related Macular DegenerationSemantic proximity Read ↗

The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?Semantic proximity Read ↗

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential MoleculesSemantic proximity Read ↗

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.Semantic proximity Read ↗

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondSemantic proximity Read ↗

[Age related macular degeneration].Semantic proximity Read ↗

The roadmap to geographic atrophy treatment: A journey of trials and promiseSemantic proximity Read ↗

Progress in defining the molecular biology of age related macular degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.